Gomekli: A Breakthrough in Treating Neurofibromatosis Type 1 with Plexiform Neurofibromas

Gomekli (mirdametinib) has become the first FDA-approved treatment for both adults and children with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas (PN)—tumors that often cannot be surgically removed. While…

Continue Reading Gomekli: A Breakthrough in Treating Neurofibromatosis Type 1 with Plexiform Neurofibromas

A Breakthrough in Avacopan Measurement: New LC-MS/MS Method Enables Precision Monitoring in Vasculitis Patient

Avacopan, a novel oral therapy for antineutrophil cytoplasmic antibody-associated vasculitis (ANCA-AAV), has changed treatment paradigms for this rare but serious disease. However, until now, a validated technique for measuring avacopan…

Continue Reading A Breakthrough in Avacopan Measurement: New LC-MS/MS Method Enables Precision Monitoring in Vasculitis Patient